MediClin AG Reports Solid First Half of 2026

MediClin AG announced a robust performance for the first half of 2026, reporting an increase in consolidated group revenues and a rise in group EBIT. The healthcare provider treated 54,708 patients, up from 53,183 the previous year. Revenues grew to EUR 386.4 million, marking a 5% increase from EUR 368.1 million previously. Group EBIT saw an upturn to EUR 26.6 million, an improvement of EUR 4.3 million from the previous year.

The Post-Acute segment contributed significantly, with revenues rising by EUR 11.5 million to EUR 263.0 million and an EBIT increase to EUR 25.6 million. Meanwhile, the Acute Care segment saw revenues rise but maintained an EBIT of EUR -1.1 million, similar to the previous year.

MediClin's outlook for 2026 remains optimistic, with anticipated revenue growth between 3.5% and 6.5%.